1. Home
  2. TENX vs VISL Comparison

TENX vs VISL Comparison

Compare TENX & VISL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TENX
  • VISL
  • Stock Information
  • Founded
  • TENX 1967
  • VISL 2002
  • Country
  • TENX United States
  • VISL United States
  • Employees
  • TENX N/A
  • VISL N/A
  • Industry
  • TENX Biotechnology: Pharmaceutical Preparations
  • VISL Telecommunications Equipment
  • Sector
  • TENX Health Care
  • VISL Telecommunications
  • Exchange
  • TENX Nasdaq
  • VISL Nasdaq
  • Market Cap
  • TENX 19.5M
  • VISL 14.9M
  • IPO Year
  • TENX N/A
  • VISL N/A
  • Fundamental
  • Price
  • TENX $5.61
  • VISL $3.60
  • Analyst Decision
  • TENX Strong Buy
  • VISL
  • Analyst Count
  • TENX 4
  • VISL 0
  • Target Price
  • TENX $20.67
  • VISL N/A
  • AVG Volume (30 Days)
  • TENX 67.9K
  • VISL 53.7K
  • Earning Date
  • TENX 11-13-2024
  • VISL 11-14-2024
  • Dividend Yield
  • TENX N/A
  • VISL N/A
  • EPS Growth
  • TENX N/A
  • VISL N/A
  • EPS
  • TENX N/A
  • VISL N/A
  • Revenue
  • TENX N/A
  • VISL $32,438,000.00
  • Revenue This Year
  • TENX N/A
  • VISL $30.41
  • Revenue Next Year
  • TENX N/A
  • VISL $11.96
  • P/E Ratio
  • TENX N/A
  • VISL N/A
  • Revenue Growth
  • TENX N/A
  • VISL 21.07
  • 52 Week Low
  • TENX $2.77
  • VISL $3.04
  • 52 Week High
  • TENX $27.36
  • VISL $8.15
  • Technical
  • Relative Strength Index (RSI)
  • TENX 54.30
  • VISL 35.23
  • Support Level
  • TENX $5.70
  • VISL $3.25
  • Resistance Level
  • TENX $6.01
  • VISL $4.08
  • Average True Range (ATR)
  • TENX 0.47
  • VISL 0.43
  • MACD
  • TENX -0.08
  • VISL 0.01
  • Stochastic Oscillator
  • TENX 12.15
  • VISL 28.67

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

About VISL Vislink Technologies Inc.

Vislink Technologies Inc is a technology business specializing in collecting, delivering, and managing high-quality, live video and associated data from the scene of the action to the viewing screen. It provides solutions for the collection of live news, sports, and entertainment events for the broadcast markets. It also furnishes the surveillance and defense markets with real-time video intelligence solutions using various tailored transmission products. The company provides professional and technical services utilizing a staff of technology experts with decades of applied knowledge and real-world experience in terrestrial microwave, satellite, fiber optic, surveillance, and wireless communications systems delivering a broad spectrum of customer solutions.

Share on Social Networks: